日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis

综述文章:靶向过氧化物酶体增殖物激活受体治疗原发性胆汁性胆管炎

Schattenberg, Jörn M; Banales, Jesus M; Hirschfield, Gideon; Trivedi, Palak; Cable, Edward E; McWherter, Charles A; Billin, Andrew N; Crittenden, Daria B; Budas, Grant

Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease

selonsertib抑制ASK1的血浆蛋白质组特征与MOSAIC糖尿病肾病随机试验的疗效相关

Petrovic, Vladimir; Whiteman, Andrew; Peach, Matt; Kim, Sam; Malkov, Vladislav A; Budas, Grant; Billin, Andrew N

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

基于人工智能的肝病临床试验入组标准和终点评估自动化

Iyer, Janani S; Juyal, Dinkar; Le, Quang; Shanis, Zahil; Pokkalla, Harsha; Pouryahya, Maryam; Pedawi, Aryan; Stanford-Moore, S Adam; Biddle-Snead, Charles; Carrasco-Zevallos, Oscar; Lin, Mary; Egger, Robert; Hoffman, Sara; Elliott, Hunter; Leidal, Kenneth; Myers, Robert P; Chung, Chuhan; Billin, Andrew N; Watkins, Timothy R; Patterson, Scott D; Resnick, Murray; Wack, Katy; Glickman, Jon; Burt, Alastair D; Loomba, Rohit; Sanyal, Arun J; Glass, Ben; Montalto, Michael C; Taylor-Weiner, Amaro; Wapinski, Ilan; Beck, Andrew H

Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study

西洛芬索治疗原发性硬化性胆管炎引起的代偿性肝硬化患者:一项开放标签的 1B 期研究

Levy, Cynthia; Caldwell, Stephen; Mantry, Parvez; Luketic, Velimir; Landis, Charles S; Huang, Jonathan; Mena, Edward; Maheshwari, Rahul; Rank, Kevin; Xu, Jun; Malkov, Vladislav A; Billin, Andrew N; Liu, Xiangyu; Lu, Xiaomin; Barchuk, William T; Watkins, Timothy R; Chung, Chuhan; Myers, Robert P; Kowdley, Kris V

Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

肝脏硬度阈值可用于预测桥接纤维化和肝硬化中的疾病进展和临床结局

Loomba, Rohit; Huang, Daniel Q; Sanyal, Arun J; Anstee, Quentin Mark; Trauner, Michael; Lawitz, Eric J; Ding, Dora; Ma, Lily; Jia, Catherine; Billin, Andrew; Huss, Ryan S; Chung, Chuhan; Goodman, Zachary; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Romero-Gómez, Manuel; Abdelmalek, Manal F; Muir, Andrew; Afdhal, Nezam; Bosch, Jaime; Harrison, Stephen; Younossi, Zobair M; Myers, Robert P

IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

IL-31 水平与胆汁淤积性和代谢性肝病患者的瘙痒症状相关,并且在非酒精性脂肪性肝炎 (NASH) 中对法尼醇 X 受体有反应。

Xu, Jun; Wang, Ya; Khoshdeli, Mina; Peach, Matt; Chuang, Jen-Chieh; Lin, Julie; Tsai, Wen-Wei; Mahadevan, Sangeetha; Minto, Wesley; Diehl, Lauri; Gupta, Ruchi; Trauner, Michael; Patel, Keyur; Noureddin, Mazen; Kowdley, Kris V; Gulamhusein, Aliya; Bowlus, Christopher L; Huss, Ryan S; Myers, Robert P; Chung, Chuhan; Billin, Andrew N

Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate

乙酰辅酶 A 羧化酶抑制剂增加伴有肝硬化的 NASH 患者的 LDL-apoB 生成率:通过非诺贝特进行预防

Mohamad Dandan, Julia Han, Sabrina Mann, Rachael Kim, Kelvin Li, Hussein Mohammed, Jen-Chieh Chuang, Kaiyi Zhu, Andrew N Billin, Ryan S Huss, Chuhan Chung, Robert P Myers, Marc Hellerstein

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers

在健康志愿者中研究新型非甾体类法尼醇X受体激动剂cilofexor的药代动力学、药效学、安全性和耐受性

Younis, Islam R; Kirby, Brian J; Billin, Andrew N; Xiao, Deqing; Song, Qinghua; Watkins, Timothy R; Othman, Ahmed A

Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA

半机制药代动力学/药效学建模和不可逆BTK抑制模拟,以支持类风湿关节炎患者Tirabrutinib的剂量选择

Meng, Amy; Humeniuk, Rita; Jürgensmeier, Juliane M; Hsueh, Chia-Hsiang; Matzkies, Franziska; Grant, Ethan; Truong, Hoa; Billin, Andrew N; Yu, Helen; Feng, Joy; Kwan, Ellen; Tarnowski, Thomas; Nelson, Cara H

A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis

不依赖于纤维化的肝脏转录组特征可识别原发性硬化性胆管炎疾病进展的驱动因素

Gindin, Yevgeniy; Chung, Chuhan; Jiang, Zhaoshi; Zhou, Jing Zhu; Xu, Jun; Billin, Andrew N; Myers, Robert P; Goodman, Zachary; Landi, Abdolamir; Houghton, Michael; Green, Richard M; Levy, Cynthia; Kowdley, Kris V; Bowlus, Christopher L; Muir, Andrew J; Trauner, Michael